CYL.F CryoLife Inc

Healthcare Health Care Equipment & Supplies Frankfurt Exchange
18.40 EUR
Close of Nov 11, 2026
17.40 40.35
Market cap
EUR 898M
P/E
-
P/B
2.21x
ROE
-6.0%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is CYL.F undervalued?

Graham number

The Graham number of CryoLife Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

CryoLife Inc fundamental analysis

No fundamental analysis for CryoLife Inc yet.

CryoLife Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About CryoLife Inc

Artivion, Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers On-X prosthetic aortic and mitral heart valves; On-X ascending aortic prosthesis; CarbonAid CO2 diffusion catheters; Chord-X ePTFE sutures; pyrolytic carbon coating services; E-vita Open NEO, a hybrid stent graft; Arcevo, an LSA hybrid stent graft system; AMDS hybrid prosthesis; and NEXUS ONE, an endovascular stent graft system. It also provides…

Full company profile